AURKA, an important factor in tumorigenesis and a potential target for SCLC therapy since its reduced expression inhibited cell proliferation (Lu et al, 2014), was significantly downregulated in all the cell lines so far tested in our experimental conditions. This evidence concerns the gene AURKA and small cell lung carcinoma.